Nonetheless, Eli Lilly shouldn't be ignored. Its weight loss drug, Zepbound, showed a 20.2% average weight loss over 72 weeks versus Wegovy's 13.7% at standard dose.

Eli Lilly’s popular diabetes drug Mounjaro proved about as effective as its older medicine Trulicity in protecting heart health in the largest and longest clinical trial of the newer GLP-1 ...

Investors were spooked by a peer's notable reduction in sales and profitability guidance. This peer was Novo Nordisk, which like Eli Lilly sells a popular drug approved specifically for obesity ...

Eli Lilly CEO David Ricks told NPR in March that every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. Novo Nordisk's effort to sell Wegovy directly to ...

Eli Lilly CEO David Ricks told NPR in March that every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website.

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

It has converted them from using the compounded versions to the brand. Eli Lilly CEO David Ricks told NPR in March that every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through ...